← Open Payments lookup

NADIA YOUNUS: Open Payments

NPI 1942573340 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,468 in 56 payments from 20 companies in 2025. Trend: 2023 $1,765 · 2024 $1,630 · 2025 $1,468

Food & beverage: $1,468
CompanyPaymentsAmount
Novo Nordisk Inc11$278
CeQur Corporation1$230
Ascensia Diabetes Care Us Inc.6$151
BETA BIONICS, INC.5$110
Corcept Therapeutics5$94
Amgen Inc.4$84
Astellas Pharma US Inc3$75
Novartis Pharmaceuticals Corporation3$75
Mannkind Corporation3$56
Amphastar Pharmaceuticals, Inc.2$43

Products named: CeQur Simplicity, Ozempic, Rybelsus, iLet Bionic Pancreas, Korlym, Veozah, LEQVIO, REPATHA.

Industry payments across TX — which companies pay providers there.